全球髂动脉支架市场规模、份额、趋势和成长分析报告（2026-2034年）

髂动脉支架市场预计将从 2025 年的 10.1 亿美元成长到 2034 年的 16.4 亿美元，2026 年至 2034 年的复合年增长率为 5.51%。

由于周边动脉疾病(PAD) 的盛行率不断上升以及生活型态相关血管疾病病例的增加，全球髂动脉支架市场正经历稳定成长。尤其是在已开发国家，人口老化显着推动了对微创血管治疗的需求。自动扩张型支架和药物释放型支架的技术进步提高了手术成功率并降低了併发症，进一步加速了市场应用。

关键成长要素包括血管内手术的增加、人们对早期诊断动脉阻塞重要性的认识不断提高，以及新兴国家医疗基础设施的扩张。住院时间和復健时间的缩短促使医生越来越多地选择支架置入术而非开放性手术。已开发国家有利的健保报销政策也促进了市场扩张。

展望未来，生物可吸收支架的持续创新和先进影像引导手术技术的进步预计将对市场产生积极影响。增加对心血管检查的投资以及将人工智慧融入血管诊断，有望进一步提高手术的精确度。亚太和拉丁美洲等新兴市场由于能够更便捷地取得先进医疗设备，预计将带来盈利的市场机会。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球髂动脉支架市场：依类型划分

• 市场分析、洞察与预测
• 自动扩张型支架
• 球囊扩张型支架
• 覆膜支架

第五章：全球髂动脉支架市场：依动脉病变类型划分

• 市场分析、洞察与预测
• 髂总动脉病变
• 严重钙化病灶
• 完全闭塞性病变

第六章 全球髂动脉支架市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第七章 全球髂动脉支架市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • Alvimedica
  • Becton
  • Dickinson And Company
  • Biotronik
  • Boston Scientific Corporation
  • B. Braun SE
  • Cook
  • Getinge AB
  • IVascular
  • Medtronic Plc

The Iliac Stent Market size is expected to reach USD 1.64 Billion in 2034 from USD 1.01 Billion (2025) growing at a CAGR of 5.51% during 2026-2034.

The Global Iliac Stent Market is witnessing steady growth due to the rising prevalence of peripheral artery disease (PAD) and increasing cases of lifestyle-related vascular disorders. Aging populations, especially in developed nations, are contributing significantly to the demand for minimally invasive vascular interventions. Technological advancements in self-expanding and drug-eluting stents have improved procedural success rates and reduced complications, further accelerating market adoption.

Key growth drivers include the increasing number of endovascular procedures, growing awareness about early diagnosis of arterial blockages, and expanding healthcare infrastructure in emerging economies. Physicians are increasingly preferring stenting procedures over open surgeries due to shorter hospital stays and faster recovery times. Favorable reimbursement policies in developed countries also support market expansion.

Looking ahead, the market is expected to benefit from ongoing innovation in bioresorbable stents and advanced imaging-guided procedures. Rising investments in cardiovascular research and the integration of AI in vascular diagnostics may further enhance procedural accuracy. Emerging markets in Asia-Pacific and Latin America are projected to offer lucrative opportunities due to improving access to advanced medical devices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Self-Expandable Stents
• Balloon-Expandable Stents
• Covered Stents

By Artery Lesions

• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Other

COMPANIES PROFILED

• Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B Braun SE, Cook, Getinge AB, iVascular, Medtronic Plc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ILIAC STENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Self-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Balloon-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Covered Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ILIAC STENT MARKET: BY ARTERY LESIONS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Artery Lesions
• 5.2. Common Iliac Artery Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Severe Calcified Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Complete Obstructive Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ILIAC STENT MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ILIAC STENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Artery Lesions
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Artery Lesions
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Artery Lesions
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Artery Lesions
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Artery Lesions
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ILIAC STENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Alvimedica
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company
  • 9.2.5 Biotronik
  • 9.2.6 Boston Scientific Corporation
  • 9.2.7 B. Braun SE
  • 9.2.8 Cook
  • 9.2.9 Getinge AB
  • 9.2.10 IVascular
  • 9.2.11 Medtronic Plc